Fortrea Holdings Inc. (FTRE)Healthcare | Biotechnology | Durham, United States | NasdaqGS
18.81 USD
-0.05
(-0.265%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 18.89 +0.08 (0.425%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:24 a.m. EDT
Fortrea Holdings presents a catastrophic long-term case driven by a 67% collapse over the last two years, with the most recent annual drop exceeding 60%. The business is fundamentally broken, posting negative earnings, shrinking revenues, and a return on equity of -15%, while carrying a debt load nearly 20 times its equity. This is not a value trap; the market has correctly priced the deterioration of the asset. The balance sheet is fragile, and the lack of a dividend confirms the company is burning cash rather than returning value. While the stock trades at a low multiple, this reflects the reality of a failing biotech firm, not a margin of safety. On the short end, the technicals are weak, though the stock recently bounced off lows, suggesting some capitulation. However, the options market screams 'crash,' with traders buying deep insurance against further ruin. With no catalyst visible to reverse the multi-year decline and a class-action lawsuit looming, the outlook remains deeply bearish. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.119703 |
| AutoARIMA | 0.122109 |
| AutoETS | 0.122663 |
| AutoTheta | 0.134345 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 9.35 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.985 |
| Excess Kurtosis | 0.02 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 213.239 |
| Revenue per Share | 28.749 |
| Market Cap | 1,788,830,976 |
| Forward P/E | 16.52 |
| Beta | 1.97 |
| Profit Margins | -3.18% |
| Previous Name | Clinical Development business of Laboratory Corporation of America Holdings |
| Website | https://www.fortrea.com |
As of Aug. 22, 2026, 4:24 a.m. EDT: Speculators are heavily positioned for downside protection, evidenced by massive open interest in deep out-of-the-money puts (strikes 7.5 and 10.0) relative to calls. The implied volatility skew is extreme, with deep puts trading at significantly higher premiums than calls, indicating a market consensus of severe further decline rather than a bounce. Call activity is sparse and concentrated near the money, lacking the volume required to signal a speculative rally.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.88411593 |
| Address1 | 8 Moore Drive |
| All Time High | 41.02 |
| All Time Low | 3.97 |
| Ask | 18.81 |
| Ask Size | 1 |
| Audit Risk | 9 |
| Average Analyst Rating | 2.3 - Buy |
| Average Daily Volume10 Day | 1,138,450 |
| Average Daily Volume3 Month | 1,452,601 |
| Average Volume | 1,452,601 |
| Average Volume10Days | 1,138,450 |
| Beta | 1.969 |
| Bid | 13.74 |
| Bid Size | 2 |
| Board Risk | 1 |
| Book Value | 5.512 |
| City | Durham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 18.81 |
| Current Ratio | 0.958 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 19.14 |
| Day Low | 18.46 |
| Debt To Equity | 213.239 |
| Display Name | Fortrea |
| Earnings Call Timestamp End | 1,785,326,400 |
| Earnings Call Timestamp Start | 1,785,326,400 |
| Earnings Timestamp | 1,785,328,200 |
| Earnings Timestamp End | 1,793,881,800 |
| Earnings Timestamp Start | 1,793,881,800 |
| Ebitda | 98,300,000 |
| Ebitda Margins | 0.036730003 |
| Enterprise To Ebitda | 27.854 |
| Enterprise To Revenue | 1.023 |
| Enterprise Value | 2,738,031,104 |
| Eps Current Year | 0.84039 |
| Eps Forward | 1.1385 |
| Eps Trailing Twelve Months | -0.83 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 18.0466 |
| Fifty Day Average Change | 0.7633991 |
| Fifty Day Average Change Percent | 0.042301547 |
| Fifty Two Week Change Percent | 88.41159 |
| Fifty Two Week High | 21.39 |
| Fifty Two Week High Change | -2.58 |
| Fifty Two Week High Change Percent | -0.120617114 |
| Fifty Two Week Low | 8.305 |
| Fifty Two Week Low Change | 10.504999 |
| Fifty Two Week Low Change Percent | 1.2649006 |
| Fifty Two Week Range | 8.305 - 21.39 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,686,922,200,000 |
| Float Shares | 93,988,281 |
| Forward Eps | 1.1385 |
| Forward P E | 16.52174 |
| Free Cashflow | 278,862,496 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 14,000 |
| Fullday Change | -0.0500011 |
| Fullday Change Percent | -0.265117 |
| Fullday Price | 18.89 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.19301 |
| Gross Profits | 516,600,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.012250001 |
| Held Percent Institutions | 1.09526 |
| Implied Shares Outstanding | 95,100,000 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. |
| Long Name | Fortrea Holdings Inc. |
| Market | us_market |
| Market Cap | 1,788,830,976 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1793665465 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -85,200,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,793,586,000 |
| Number Of Analyst Opinions | 11 |
| Open | 18.765 |
| Operating Cashflow | 227,800,000 |
| Operating Margins | 0.025799999 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.34 |
| Phone | 877 495 0816 |
| Post Market Change | 0.07999992 |
| Post Market Change Percent | 0.4253053 |
| Post Market Price | 18.89 |
| Post Market Time | 1,787,959,806 |
| Prev Name | Clinical Development business of Laboratory Corporation of America Holdings |
| Previous Close | 18.86 |
| Price Eps Current Year | 22.382463 |
| Price Hint | 2 |
| Price To Book | 3.4125543 |
| Price To Sales Trailing12 Months | 0.6683471 |
| Profit Margins | -0.03183 |
| Quick Ratio | 0.854 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.33333 |
| Region | US |
| Regular Market Change | -0.0500011 |
| Regular Market Change Percent | -0.265117 |
| Regular Market Day High | 19.14 |
| Regular Market Day Low | 18.46 |
| Regular Market Day Range | 18.46 - 19.14 |
| Regular Market Open | 18.765 |
| Regular Market Previous Close | 18.86 |
| Regular Market Price | 18.81 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 1,140,969 |
| Return On Assets | 0.00583 |
| Return On Equity | -0.15303999 |
| Revenue Growth | -0.045 |
| Revenue Per Share | 28.749 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 95,100,000 |
| Shares Percent Shares Out | 0.120900005 |
| Shares Short | 11,501,125 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 10,256,753 |
| Short Name | Fortrea Holdings Inc. |
| Short Percent Of Float | 0.142 |
| Short Ratio | 6.98 |
| Source Interval | 15 |
| State | NC |
| Symbol | FTRE |
| Target High Price | 26.0 |
| Target Low Price | 13.0 |
| Target Mean Price | 20.54545 |
| Target Median Price | 22.0 |
| Total Cash | 168,600,000 |
| Total Cash Per Share | 1.773 |
| Total Debt | 1,117,799,936 |
| Total Revenue | 2,676,499,968 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.83 |
| Trailing Peg Ratio | 0.3442 |
| Triggerable | 1 |
| Two Hundred Day Average | 14.3936 |
| Two Hundred Day Average Change | 4.416399 |
| Two Hundred Day Average Change Percent | 0.30683073 |
| Type Disp | Equity |
| Volume | 1,140,969 |
| Website | https://www.fortrea.com |
| Zip | 27,709 |